Edoc Acquisition Corp. (ADOC) Adds $75M to Calidi Biotherapeutics Deal
Edoc (NASDAQ:ADOC) has added a $75 million common stock purchase agreement to its combination with biotech firm Calidi.
As a part of the agreement, Calidi will be able to call upon an unnamed investor to purchase up to $75 million in company stock over a three-year period following close. ...READ MORE
